UiPath, Inc. (PATH) Faces Pressure Amid Weak Software Infrastructure Industry Momentum

UiPath, Inc. (NYSE:PATH) is one of the 10 best low-priced AI stocks to buy now.

As of March 4, 2026, analyst sentiment remains largely mixed, with UiPath, Inc. (NYSE:PATH) facing pressure amid a 15% decline in the software infrastructure sector so far this year. The stock is down approximately 30% during the same period.

Amid weak overall momentum, UiPath, Inc. (NYSE:PATH) is expected to grow its agentic AI footprint while competition intensifies.

As of February 23, 2026, it targeted revenue cycle management with the launch of healthcare automation services, with early users reporting review time reductions of up to 90%. Moreover, in order to strengthen its AI-driven financial crime compliance capabilities in banking and to automate AML and KYC operations, UiPath previously purchased WorkFusion on February 6, 2026.

Meanwhile, two days later, concerns about competition grew when shares dropped 3.60% following Anthropic's announcement that it was acquiring Vercept to improve Claude's computer-use skills. This step directly overlaps with UiPath's automation focus. Anthropic also referenced Claude Sonnet 4.6, scoring 72.50% on the OSWorld benchmark. This was an increase from 15.00% in late 2024, demonstrating growing AI advancement in executing multi-step tasks within live applications.

UiPath, Inc. (NYSE:PATH) creates corporate automation software that utilizes robotic process automation and agentic AI to streamline processes, increase compliance, and boost operational efficiency in healthcare, financial services, telecommunications, and public sector organizations.

While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.